Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(NY:
BLCO
)
18.78
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Oct 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
18.78
Bid (Size)
18.30 (1)
Ask (Size)
29.86 (1)
Prev. Close
18.78
Today's Range
18.78 - 18.78
52wk Range
13.16 - 21.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Nike Reports Weak Sales, Joins Lamb Weston And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
October 02, 2024
Via
Benzinga
Bausch + Lomb Launches Opal™ Digital Marketplace in the United States
October 01, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Performance
YTD
+10.99%
+10.99%
1 Month
+19.24%
+19.24%
3 Month
+23.15%
+23.15%
6 Month
+14.37%
+14.37%
1 Year
+10.67%
+10.67%
More News
Read More
Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value
September 25, 2024
Via
MarketBeat
Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why Bausch + Lomb Rallied Today
September 16, 2024
Via
The Motley Fool
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
July 29, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday
September 18, 2024
Via
Benzinga
Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues
September 16, 2024
Via
Benzinga
Topics
Supply Chain
Exposures
Supply Chain
Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?
September 16, 2024
Via
Investor's Business Daily
Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday
September 16, 2024
Via
Benzinga
Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday?
July 31, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Bausch + Lomb Announces Second-Quarter 2024 Results
July 31, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Wall Street Remains On Track For AMD-Led Rebound Ahead Of Fed Decision, Meta Earnings: Analyst Says 'The Bull Tends To Remain' Despite Near-Time Volatility
July 31, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31
July 11, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 24, 2024
Via
Benzinga
Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief
July 08, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Why Is Clearside Biomedical Stock Gaining Today?
June 25, 2024
Via
Benzinga
Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
June 17, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
June 10, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
June 03, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results
May 29, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®
May 28, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens
May 28, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Do You Have Your Eye On Vision Care Stocks?
May 20, 2024
Via
Talk Markets
American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday
May 06, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.